Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955).

N. van Zandwijk; E.F. Smit; G. Kramer; F.M. Schramel; S. Gans; J. Festen; A. Termeer; N.J.J. Schlösser; C. Debruyne; D. Curran; G. Giaccone

Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955).

Translated title of the contribution: Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955).

N. van Zandwijk
, E.F. Smit
, G. Kramer
, F.M. Schramel
, S. Gans
, J. Festen
, A. Termeer
, N.J.J. Schlösser
, C. Debruyne
, D. Curran
, G. Giaccone

Department of Pulmonary Diseases

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955).
Original language	Undefined/Unknown
Pages (from-to)	2658-2664
Number of pages	7
Journal	Journal of Clinical Oncology
Volume	18
Issue number	14
Publication status	Published - 2000

Cite this

van Zandwijk, N., Smit, E. F., Kramer, G., Schramel, F. M., Gans, S., Festen, J., Termeer, A., Schlösser, N. J. J., Debruyne, C., Curran, D., & Giaccone, G. (2000). Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955). Journal of Clinical Oncology, 18(14), 2658-2664.

van Zandwijk, N. ; Smit, E.F. ; Kramer, G. et al. / Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955). In: Journal of Clinical Oncology. 2000 ; Vol. 18, No. 14. pp. 2658-2664.

@article{6bdd2438741f43ef96ed0f25245c6603,

title = "Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955).",

author = "\{van Zandwijk\}, N. and E.F. Smit and G. Kramer and F.M. Schramel and S. Gans and J. Festen and A. Termeer and N.J.J. Schl{\"o}sser and C. Debruyne and D. Curran and G. Giaccone",

year = "2000",

language = "Undefined/Unknown",

volume = "18",

pages = "2658--2664",

journal = "Journal of Clinical Oncology",

issn = "0732-183X",

publisher = "Lippincott Williams \& Wilkins",

number = "14",

}

van Zandwijk, N, Smit, EF, Kramer, G, Schramel, FM, Gans, S, Festen, J, Termeer, A, Schlösser, NJJ, Debruyne, C, Curran, D & Giaccone, G 2000, 'Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955).', Journal of Clinical Oncology, vol. 18, no. 14, pp. 2658-2664.

Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955). / van Zandwijk, N.; Smit, E.F.; Kramer, G. et al.
In: Journal of Clinical Oncology, Vol. 18, No. 14, 2000, p. 2658-2664.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955).

AU - van Zandwijk, N.

AU - Smit, E.F.

AU - Kramer, G.

AU - Schramel, F.M.

AU - Gans, S.

AU - Festen, J.

AU - Termeer, A.

AU - Schlösser, N.J.J.

AU - Debruyne, C.

AU - Curran, D.

AU - Giaccone, G.

PY - 2000

Y1 - 2000

M3 - Article

SN - 0732-183X

VL - 18

SP - 2658

EP - 2664

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

IS - 14

ER -

van Zandwijk N, Smit EF, Kramer G, Schramel FM, Gans S, Festen J et al. Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage IIIA N2 non-small-cell lung cancer: a phase II study of the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group (EORTC 08955). Journal of Clinical Oncology. 2000;18(14):2658-2664.